Publications
211
Citations
794
Est. group size
~2
Recurring co-author estimate
Active years
33
Publishing since 1994
Saba Shafi's work centers on cancer immunology and diagnostics, particularly how immune markers like PD-1/PD-L1 and tumor-infiltrating lymphocytes relate to outcomes in cancers such as head and neck, lung, breast, and melanoma. Recent work also touches on quantitative imaging/AI-based pathology analysis and, in a few papers, unrelated topics like plant-based drug biosynthesis and genetic variants in allergic rhinitis. Much of the output stems from large collaborative clinical trial datasets rather than a single sustained research direction.
Publication counts were low and steady from 2017-2020, rose sharply in 2021-2022, spiked dramatically in 2023 (largely due to a cluster of supplementary data releases tied to one study), then dropped back to a lower, more modest level in 2024-2026.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Nanobodies: A Promising Toolkit for Diagnostic Applications
SmartMat · 2026
- <i>De Novo</i> Biosynthesis of Polyphyllin V in <i>Nicotiana benthamiana</i> through Pathway Reconstruction and UDP-Sugar Engineering
ACS Synthetic Biology · 2026
- Pathologist-Read vs AI-Driven Assessment of Tumor-Infiltrating Lymphocytes in Melanoma
JAMA Network Open · 2025
- Advances in antitumor activity and mechanism of natural steroidal saponins: A review of advances, challenges, and future prospects
Phytomedicine · 2024
- Molecular investigation of vitamin D receptor (VDR) genetic variants and their impact on VDR mRNA and serum vitamin D levels in allergic rhinitis in an Indian population: A case–control study
International Journal of Immunogenetics · 2024
- Phase II Window Study of Olaparib Alone or with Cisplatin or Durvalumab in Operable Head and Neck Cancer
Cancer Research Communications · 2023
- Digital Spatial Profiling Links Beta-2-microglobulin Expression with Immune Checkpoint Blockade Outcomes in Head and Neck Squamous Cell Carcinoma
Cancer Research Communications · 2023
- Image analysis-based tumor infiltrating lymphocytes measurement predicts breast cancer pathologic complete response in SWOG S0800 neoadjuvant chemotherapy trial
npj Breast Cancer · 2023
- New Therapies in Melanoma: Current Trends, Evolving Paradigms, and Future Perspectives
Cutis · 2023
- Quantitative, Spatially Defined Expression of Leukocyte-associated Immunoglobulin-like Receptor in Non–small Cell Lung Cancer
Cancer Research Communications · 2023
- Supplementary Table 2 from Association of PD-1/PD-L1 Co-location with Immunotherapy Outcomes in Non–Small Cell Lung Cancer
2023
- Supplementary Figure 2 from Association of PD-1/PD-L1 Co-location with Immunotherapy Outcomes in Non–Small Cell Lung Cancer
2023
- Supplementary Figure 1 from Association of PD-1/PD-L1 Co-location with Immunotherapy Outcomes in Non–Small Cell Lung Cancer
2023
- Data from Association of PD-1/PD-L1 Co-location with Immunotherapy Outcomes in Non–Small Cell Lung Cancer
2023
- Supplementary Figure 1 from Association of PD-1/PD-L1 Co-location with Immunotherapy Outcomes in Non–Small Cell Lung Cancer
2023
- Journal of Clinical Oncology×8
- Ibnosina Journal of Medicine and Biomedical Sciences×4
- Cancer Research Communications×3
- Genes Chromosomes and Cancer×3
- American Journal of Clinical Pathology×3
- Kai He
Medicine · The Ohio State University
- Shurui Cai
Medicine · The Ohio State University
- Songzhu Zhao
Medicine · The Ohio State University
- Adam Khorasanchi
Medicine · The Ohio State University
- Na Zhuo
Medicine · Purdue University West Lafayette
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile